Fresenius Hits Dr. Reddy's With Diprivan IP Suit
By Aaron Taube ( May 24, 2013, 4:36 PM EDT) -- A subsidiary of Fresenius SE & Co. KGaA on Thursday accused the Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. and a U.S. unit of infringing four of its patents when Dr. Reddy's applied to produce a generic version of the sedative Diprivan....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.